Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian share markets slip
Thu, 19 Jun 01:30 pm

After trading flat, Indian share markets fell in the negative territory in the post-noon trading session. Sectoral indices are trading mixed with oil and gas and metal stocks being the biggest losers whereas IT and auto stocks are leading the gains.

BSE-Sensex is down 94 points and NSE-Nifty is trading 31 points down. BSE Mid Cap is trading 0.4% down and BSE Small BSE Small Cap index is trading down by 0.2%. The rupee is trading at 59.91 to the US dollar.

Majority of the pharma stocks are trading in the red with Strides Acrolab and J B Chemicals being the biggest losers. However, Natco Pharma and Cadila Healthcare are among the few stocks trading in the green. As per a leading financial daily, Cipla has entered into an agreement with Hyderabad based company Hetero to launch a biosimilar version of Darbepoetin alfa. The product to be launched under the brand name 'Actorise' is indicated for the treatment of anaemia caused due to chronic kidney disease. The company had launched its first biosimilar product 'Etacept' last year in collaboration with a partner from China. Cipla's stock is currently trading down marginally.

Most of the auto stocks are trading in the green with Maharashtra Scooters and Tata Motors being among the major gainers. But Maruti Suzuki and Force Motors are among the few stocks trading in the red. As per a leading financial daily, Maruti Suzuki commissioned its 1 MW photovoltaic solar power plant at its Manesar facility. The facility has been built at a cost of Rs 103 m and will enable the company to offset 1,200 tonnes of carbon dioxide emissions every year. The power generated from the solar plant is synchronized with the natural gas-based captive power plant and will complement the power requirement in the facility. Maruti Suzuki's stock is currently trading down by 2.2%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets slip". Click here!